Literature DB >> 31741887

The association between tumor's location and cervical lymph nodes metastasis in papillary thyroid cancer.

Ting-Ting Zhang1,2, Xiu-Zhu Qi2,3, Jian-Ping Chen4, Rong-Liang Shi1,2, Shi-Shuai Wen1,2, Yu-Long Wang1,2, Qing-Hai Ji1,2, Qiang Shen1,2, Yong-Xue Zhu1,2, Ning Qu1,2.   

Abstract

BACKGROUND: Papillary thyroid cancer (PTC) has a strong propensity to metastasize to the cervical lymph nodes. Little was known currently about whether tumor's location would influence the risk of lymph node metastasis in PTC.
METHODS: The study enrolled PTC patients who underwent primary surgical therapy in our center for small unifocal tumor. The tumor's location was evaluated by ultrasound in three axes, three planes and 3D space. Logistic univariate and multivariate analysis were applied to explore the association between tumors' location and the risk of lymph node metastasis in PTC. Different localization methods of thyroid tumors were evaluated using ROC curve.
RESULTS: Totally 1,266 PTC patients were enrolled in this study. Univariate and multivariate analyses showed that gender, age, tumor size and tumor's location (in longitudinal axis, longitudinal sagittal plane, longitudinal coronal plane, sagittal coronal plane and 3D space) was associated with central lymph node dissection (CLND); gender, tumor size and tumor's location (in longitudinal axis, coronal axis, longitudinal sagittal plane, longitudinal coronal plane, sagittal coronal plane and 3D space) was related with lateral lymph node dissection (LLND) (P<0.05). In the ROC curve analysis, the 3D location showed the highest predictive value of lymph node metastasis (C-statistics: 0.724 for CLNM; 0.763 for LLNM). The middle posterior lateral (OR=2.575, P=0.028), inferior anterior central (OR=2.829, P=0.016), inferior posterior lateral (OR=2.759, P=0.039) and isthmus tumors (OR=4.526, P=0.001) were at a higher risk of CLNM, and the middle anterior central tumors (OR=0.102, P=0.015) were related with lower risk of LLNM.
CONCLUSIONS: Stereotactic localization showed the highest predictive value of lymph node metastasis. The middle posterior lateral, inferior anterior central, inferior posterior lateral and isthmus tumors were at a higher risk of CLNM when compared to other locations. For such patients, careful preoperative evaluation of nodal status should be done. 2019 Gland Surgery. All rights reserved.

Entities:  

Keywords:  Papillary thyroid cancer (PTC); lymph node metastasis; predictive factor; tumor’s location; ultrasound

Year:  2019        PMID: 31741887      PMCID: PMC6842756          DOI: 10.21037/gs.2019.10.02

Source DB:  PubMed          Journal:  Gland Surg        ISSN: 2227-684X


  21 in total

1.  Features of papillary thyroid microcarcinoma associated with lateral cervical lymph node metastasis.

Authors:  Min Ji Jeon; Mi Sun Chung; Hyemi Kwon; Mijin Kim; Suyeon Park; Jung Hwan Baek; Dong Eun Song; Tae-Yon Sung; Suck Joon Hong; Tae Yong Kim; Won Bae Kim; Young Kee Shong; Jeong Hyun Lee; Won Gu Kim
Journal:  Clin Endocrinol (Oxf)       Date:  2017-03-30       Impact factor: 3.478

2.  Clinicopathologic Predictive Factors of Cervical Lymph Node Metastasis in Differentiated Thyroid Cancer.

Authors:  Ronghao Sun; Hua Zhang; Kun Liu; Jinchuan Fan; Guojun Li; Xicheng Song; Chao Li
Journal:  Acta Otorrinolaringol Esp (Engl Ed)       Date:  2017-11-20

3.  An analysis of factors predicting lateral cervical nodal metastases in papillary carcinoma of the thyroid.

Authors:  Jason P Hunt; Luke O Buchmann; Libo Wang; Dev Abraham
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2011-11

4.  An Evaluation of Clinicopathological Factors Effective in the Development of Central and Lateral Lymph Node Metastasis in Papillary Thyroid Cancer.

Authors:  Betul Aydin Buyruk; Nur Kebapci; Goknur Yorulmaz; Aytuğ Buyruk; Mahmut Kebapci
Journal:  J Natl Med Assoc       Date:  2017-08-07       Impact factor: 1.798

5.  Prophylactic central compartment lymph node dissection in papillary thyroid carcinoma: clinical implications derived from the first prospective randomized controlled single institution study.

Authors:  D Viola; G Materazzi; L Valerio; E Molinaro; L Agate; P Faviana; V Seccia; E Sensi; C Romei; P Piaggi; L Torregrossa; S Sellari-Franceschini; F Basolo; P Vitti; R Elisei; P Miccoli
Journal:  J Clin Endocrinol Metab       Date:  2015-01-15       Impact factor: 5.958

Review 6.  Surgical management of the lateral neck compartment for metastatic thyroid cancer.

Authors:  Henning Dralle; Andreas Machens
Journal:  Curr Opin Oncol       Date:  2013-01       Impact factor: 3.645

Review 7.  Thyroid cancer nodal metastases: biologic significance and therapeutic considerations.

Authors:  S K Grebe; I D Hay
Journal:  Surg Oncol Clin N Am       Date:  1996-01       Impact factor: 3.495

8.  Tumor location-dependent skip lateral cervical lymph node metastasis in papillary thyroid cancer.

Authors:  Yoon Se Lee; Sung-Chan Shin; Yun-Sung Lim; Jin-Choon Lee; Soo-Geun Wang; Seok-Man Son; In-Ju Kim; Byung-Joo Lee
Journal:  Head Neck       Date:  2014-01-13       Impact factor: 3.147

9.  Mediastinal Lymph Node Metastases in Thyroid Cancer: Characteristics, Predictive Factors, and Prognosis.

Authors:  Ting-Ting Zhang; Ning Qu; Jia-Qian Hu; Rong-Liang Shi; Duo Wen; Guo-Hua Sun; Qing-Hai Ji
Journal:  Int J Endocrinol       Date:  2017-11-12       Impact factor: 3.257

10.  Predictors of lymph nodes posterior to the right recurrent laryngeal nerve metastasis in patients with papillary thyroid carcinoma: A retrospective study.

Authors:  Jiru Yuan; Jinghua Li; Xiaoyi Chen; Zhenwei Zhong; Zhengbo Chen; Ying Yin; Jialin Du; Shuzhen Cong; Zeyu Wu
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

View more
  8 in total

1.  Clinical implications of Delphian lymph node metastasis in papillary thyroid carcinoma.

Authors:  Jiang Zhu; Rui Huang; Ping Yu; Daixing Hu; Haoyu Ren; Chun Huang; Xinliang Su
Journal:  Gland Surg       Date:  2021-01

2.  Evaluation of the diagnostic performance of contrast-enhanced ultrasound combined with BRAF V600E gene detection in nodules of unclear significance by thyroid fine-needle aspiration.

Authors:  Xi Zhu; Xuyang Peng; Lei Zhu; Lidan Xie; Feng Cheng; Bin Zhou
Journal:  Gland Surg       Date:  2021-01

3.  Prediction Model of Pathologic Central Lymph Node Negativity in cN0 Papillary Thyroid Carcinoma.

Authors:  Xiujie Shu; Lingfeng Tang; Daixing Hu; Yuanyuan Wang; Ping Yu; Zhixin Yang; Chang Deng; Denghui Wang; Xinliang Su
Journal:  Front Oncol       Date:  2021-09-27       Impact factor: 6.244

4.  A Specific Predicting Model for Screening Skip Metastasis From Patients With Negative Central Lymph Nodes Metastasis in Papillary Thyroid Cancer.

Authors:  Zheyu Yang; Yu Heng; Qiwu Zhao; Zichao Cao; Lei Tao; Weihua Qiu; Wei Cai
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-30       Impact factor: 5.555

5.  Analysis of the Clinical Value of Delphian Lymph Node Metastasis in Papillary Thyroid Carcinoma.

Authors:  Qiumei Zuo; Xin Chen; Jingyu Yang; Shuang Qiu; Yuan Zhao; Jianwei Sun
Journal:  J Oncol       Date:  2022-06-10       Impact factor: 4.501

6.  Isthmic Papillary Thyroid Carcinoma Presents a Unique Pattern of Central Lymph Node Metastasis.

Authors:  Liguang Zhou; Chao Gao; Haipeng Li; Weili Liang; Qingdong Zeng; Bo Chen
Journal:  Cancer Manag Res       Date:  2020-05-19       Impact factor: 3.989

7.  Surgical Extent of Central Lymph Node Dissection for Papillary Thyroid Carcinoma Located in the Isthmus: A Propensity Scoring Matched Study.

Authors:  Yanjie Shuai; Kai Yue; Yuansheng Duan; Mengqian Zhou; Yan Fang; Jin Liu; Dandan Liu; Chao Jing; Yansheng Wu; Xudong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-06-15       Impact factor: 5.555

8.  Effect of Tumor Location on the Risk of Bilateral Central Lymph Node Metastasis in Unilateral 1-4 cm Papillary Thyroid Carcinoma.

Authors:  Nan Liu; Bo Chen; Luchuan Li; Qingdong Zeng; Lei Sheng; Bin Zhang; Bin Lv
Journal:  Cancer Manag Res       Date:  2021-07-20       Impact factor: 3.989

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.